SCHEMBL4566263

SCHEMBL4566263

CCCNC(=O)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 9/20 0.46
AURKB Q96GD4 9/20 0.46
CDK1 P06493 8/20 0.46
CCNB1 P14635 8/20 0.46
CDK2 P24941 7/20 0.46
CHEK1 O14757 5/20 0.46
FGFR1 P11362 4/20 0.46
FGFR2 P21802 4/20 0.46
FGFR3 P22607 4/20 0.46
KDR P35968 3/20 0.46
BMPR1B O00238 1/20 0.46
CDC7 O00311 1/20 0.46
PLK4 O00444 1/20 0.46
STK25 O00506 1/20 0.46
GAK O14976 1/20 0.46
EPHB6 O15197 1/20 0.46
BUB1 O43683 1/20 0.46
JAK2 O60674 1/20 0.46
RPS6KA5 O75582 1/20 0.46
RPS6KA4 O75676 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12027307 0.92 AURKA (0.46) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL10240215 0.91 AURKA (0.44) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL14310758 0.90 AURKA (0.47) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL14310757 0.88 AURKA (0.47) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL10240122 0.88 PDPK1 (0.48) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL10240218 0.88 AURKA (0.49) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL10240195 0.88 AURKA (0.50) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL8299907 0.88 AURKA (0.51) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL10240239 0.88 AURKA (0.46) AURKAAURKBCDK1CCNB1CDK2
SCHEMBL10240213 0.88 AURKA (0.46) AURKAAURKBCDK1CCNB1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2043635-A2 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-04-08 EP disclosed
WO-2008001101-A2 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-01-03 WO disclosed